June 2016 Birmingham
Target Ovarian Cancer hosted our second ‘Ask the experts’ conference in Birmingham, bringing together eminent clinicians from across the UK to discuss the latest science, theory and advances in ovarian cancer, and answer your questions. Watch our series of videos to catch up on all of the speaker presentations from the day.
Please note that some of the content may be upsetting or troubling for some viewers. If you have any questions or concerns about the presentations, please contact the Supportive Services team on 020 7923 5475 or email@example.com
- Mr Adam Rosenthal - Familial risk of ovarian cancer, what have we learnt so far?
- Mrs Sudha Sundar - Accurate and timely diagnosis of ovarian cancer
- Mr Janos Balega - Advances in surgery for ovarian cancer
- Dr Andrew Clamp - Advances in targeted treatment for ovarian cancer
- Why is family history important?
- What is a significant family history?
- How do you assess your risk?
- What can you do to reduce risk if you are found to have a BRCA1 or BRCA2 gene mutation?
- When should I have risk reducing surgery?
- Should I have HRT if I’ve had the surgery?
- What are the alternatives to surgery?
- Challenges with the current diagnostic pathway for ovarian cancer
- How could they be improved?
- Clinical trials to assist timely diagnosis
- The importance of quality surgery
- The types of surgery – standard, radical and extensive
- How can more extensive surgery be carried out safely?
- What is targeted therapy?
- What are PARP inhibitors?
- What is immunotherapy?
Justin Champagne - The role of a research advocate
Rebecca Rennison - Shaping public policy: 'Pathfinder' research and campaigning
Dr Srinivasan Madhusudan - Targetting flap endonuclease 1 (FEN1) for personalisation of ovarian cancer therapy
June 2014 Manchester
Target Ovarian Cancer hosted a free information event for all women with ovarian cancer and their family and friends. The event included presentations from eminent experts who presented the most up to date knowledge on a series of topics relating to ovarian cancer.
In a new series of podcasts, you will hear from a range of experts about the latest in screening, treatments and surgery.
Podcast one - screening
In this first podcast, Professor Ian Jacobs, Vice President and Dean of the Faculty of Medical/Human Sciences at the University of Manchester, speaks about the status of ovarian cancer screening and research funded by The Eve Appeal, Cancer Research UK and the Medical Research Council.
Podcast two - emerging treatments
In this second podcast, Dr Andrew Clamp, Clinical Senior Lecturer in Medical Oncology at the Christie Hospital, Manchester, and Professor Gordon Jayson, Professor of Medical Oncology at the Christie Hospital, Manchester speak about emerging treatments.
Podcast three - surgery
In the third of our series, we hear from Professor Richard Edmondson, Professor of Gynaecological Oncology at the University of Manchester, speaking about the latest developments in surgery.
Podcast four - Target Ovarian Cancer research
In the fourth of our series, we hear from Professor Henry Kitchener, Chair of Gynaecological Oncology at the University of Manchester, and Chair of the Scientific Advisory Board for Target Ovarian Cancer, speaking about Target Ovarian Cancer funded research.
Podcast five - the role of the clinical nurse specialist
In the last of this series of podcasts, we hear from Clara Dennis, Clinical Nurse Specialist (CNS) at St Mary’s Hospital, Manchester and Helen Savage, CNS at the Christie Hospital about the role of the clinical nurse specialist as the 'key worker', providing information, advice and support to women and their families from diagnosis onwards.
Attend an event
Keep an eye on our events listings for future events to attend.
Our experts’ suggestions are their own and not endorsed by Target Ovarian Cancer staff. We do, however, strongly recommend that you seek professional advice on your personal circumstances before acting on any advice you receive.